Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NaltRec: Long-acting naltrexone for opioid addiction
2017-004706-18Phase 4Completed
- Sponsor
- Akershus University Hospital
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of naltrexone in opioid use disorder (OUD), sponsored by Akershus University Hospital. Primary endpoint: Primary endpoints at week 26 and week 52 after treatment discontinuation. Started Jan 2018; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on 2017-004706-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004706-18.